Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase‐9 inhibition

OBJECTIVE: Delayed cerebral ischemia (DCI) is an independent risk factor for poor outcome after aneurysmal subarachnoid hemorrhage (SAH) and is multifactorial in etiology. While prior studies have suggested a role for matrix metalloproteinase‐9 (MMP‐9) in early brain injury after SAH, its contributi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Vellimana, Ananth K., Zhou, Meng‐Liang, Singh, Itender, Aum, Diane J., Nelson, James W., Harris, Glenn R., Athiraman, Umeshkumar, Han, Byung H., Zipfel, Gregory J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740245/
https://ncbi.nlm.nih.gov/pubmed/29296615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars